David A. Santos, EVP, Chief Commercial Officer: Rigel Pharmaceuticals RIGL Sell · Filed 24/02/06

Trade details

Type: Insider sale
Amount: $10,166.52
Shares · price: 8,918 sh · $1.14 a share
Held after: 349,093 sh
Stock: Rigel Pharmaceuticals RIGL
Person: David A. SantosEVP, Chief Commercial Officer
Trade date: 24/02/05
Filed: 24/02/06
Days to filing: 1 days

Sold 2.5% of holdings

Share of holding sold: 2.5%

Rigel Pharmaceuticals trades, last 26 weeks

What else happened in Rigel Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 24/01/06~24/03/06

David A. Santos's recent trades

David A. SantosEVP, Chief Commercial Officer
SellRigel Pharmaceuticals
Sell
Rigel Pharmaceuticals
RIGL
$44.5K
2,125 sh
$44.5K
Filed 25/02/06
Traded 25/02/04
David A. SantosEVP, Chief Commercial Officer
SellRigel Pharmaceuticals
Sell
Rigel Pharmaceuticals
RIGL
$39.4K
1,796 sh
$39.4K
Filed 25/02/06
Traded 25/02/05
David A. SantosOfficer
Planned saleRigel Pharmaceuticals
Planned sale
Rigel Pharmaceuticals
RIGL
$39.4K
1,796 sh
$39.4K
Filed 25/02/05
Traded 25/02/05
David A. SantosOfficer
Planned saleRigel Pharmaceuticals
Planned sale
Rigel Pharmaceuticals
RIGL
$44.5K
2,125 sh
$44.5K
Filed 25/02/04
Traded 25/02/04
David A. SantosEVP, Chief Commercial Officer
SellRigel Pharmaceuticals
Sell
Rigel Pharmaceuticals
RIGL
$6,329
5,601 sh
$6,329
Filed 24/02/06
Traded 24/02/02

David A. Santos, Chief Officer — sold $10.2K of Rigel Pharmaceuticals RIGL · 2.5% of holdings | Whalegun